Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

Identification of actinomycin D as a specific inhibitor of the alternative pathway of peptidoglycan biosynthesis


Peptidoglycan is an indispensable component of bacterial cell walls. We recently discovered an alternative peptidoglycan biosynthetic pathway, which involves two enzymes, MurD2 and MurL, catalyzing the ligation of l-Glu to UDP-MurNAc-l-Ala and epimerization of the terminal l-Glu of the MurD2 product, respectively. Because the pathway operates in Xanthomonas oryze, a pathogen causing bacterial blight of rice, we searched for specific inhibitors from metabolites produced by actinomycetes to obtain a lead compound to function as an agrochemical. Actinomycin D was isolated from Streptomyces parvulus NBRC 13193 as a specific inhibitor of the pathway. In vitro analysis indicated that actinomycin D inhibited the MurD2 reaction.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2


  1. van Heijenoort J. Recent advances in the formation of the bacterial peptidoglycan monomer unit. Nat Prod Rep 2001;18:503–19.

    Article  Google Scholar 

  2. El Zoeiby A, Sanschagrin F, Levesque RC. Structure and function of the Mur enzymes: development of novel inhibitors. Mol Microbiol 2003;47:1–12.

    Article  CAS  Google Scholar 

  3. Feng R, Satoh Y, Ogasawara Y, Yoshimura T, Dairi T. A glycopeptidyl-glutamate epimerase for bacterial peptidoglycan biosynthesis. J Am Chem Soc 2017;139:4243–5.

    Article  CAS  Google Scholar 

  4. Feng R, Satoh Y, Morita H, Ogasawara Y, Dairi T. Amino acid residues recognizing isomeric glutamate substrates in UDP- N-acetylmuramic acid-l-alanine-glutamate synthetases. ACS Chem Biol 2019;14:975–8.

    Article  CAS  Google Scholar 

  5. Ginell S, Lessinger L, Berman HM. The crystal and molecular structure of the anticancer drug actinomycin D—some explanations for its unusual properties. Biopolymers 1988;27:843–64.

    Article  CAS  Google Scholar 

  6. Waksman SA, Geiger WB, Reynolds DM. Strain specificity and production of antibiotic substances: VII. Production of actinomycin by different actinomycetes. Proc Natl Acad Sci USA 1946;32:117–20.

    Article  CAS  Google Scholar 

  7. Yu C, Tseng YY. NMR study of the solution conformation of actinomycin D. Eur J Biochem 1992;209:181–7.

    Article  CAS  Google Scholar 

  8. Zhang X, Ye X, Chai W, Lian XY, Zhang Z. New metabolites and bioactive actinomycins from marine-derived streptomyces sp. ZZ338. Mar Drugs 2016;14:E181.

    Article  Google Scholar 

  9. Kirk JM. The mode of action of actinomycin D. Biochim Biophys Acta 1960;42:167–9.

    Article  CAS  Google Scholar 

  10. Takusagawa F, Dabrow M, Neidle S, Berman HM. The structure of a pseudo intercalated complex between actinomycin and the DNA binding sequence d(GpC). Nature 1982;296:466–9.

    Article  CAS  Google Scholar 

Download references


This study was supported in part by Grants-in-Aid for Research on Innovative Areas from MEXT, Japan (JSPS KAKENHI Grant Number 16H06452 to T.D.), Grants-in-Aid for Scientific Research from JSPS (18H03937 to T.D. and 18K05449 to Y.O.) and the Uehara Memorial Foundation to T.D. The authors thank Mr. Masafumi Nakao for the assistance in the preparation of UDP-MurNAc-L-Ala. The authors also thank Dr. Eri Fukushi at the GC-MS and NMR Laboratory, Graduate School of Agriculture, Hokkaido University, for acquiring the NMR spectra. We thank Kate Fox, DPhil, from Edanz Group ( for editing a draft of this manuscript.

Author information

Authors and Affiliations


Corresponding authors

Correspondence to Yasushi Ogasawara or Tohru Dairi.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ogasawara, Y., Shimizu, Y., Sato, Y. et al. Identification of actinomycin D as a specific inhibitor of the alternative pathway of peptidoglycan biosynthesis. J Antibiot 73, 125–127 (2020).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links